FDA Urged To Give Troubled Compounders A 2nd Look

A consumer advocacy group on Thursday demanded that the U.S. Food and Drug Administration reinspect each compounding pharmacy that has received an FDA warning letter since 2003, to prevent incidents like...

Already a subscriber? Click here to view full article